Skip to main content
main-content

Vasculitis

Giant cell arteritis

13-06-2019 | Giant cell arteritis | EULAR 2019 | News

Further support for tocilizumab use in giant cell arteritis

More than a third of patients with giant cell arteritis remission who discontinue tocilizumab treatment after 1 year remain in clinical remission for a further 2 years, suggest follow-up results from the GiACTA trial.

20-11-2018 | Polymyalgia rheumatica | Article

Comorbidities in polymyalgia rheumatica: A systematic review

Partington R et al. Arthritis Res Ther 2018; 20: 258. doi: 10.1186/s13075-018-1757-y

Support for PET imaging in early giant cell arteritis diagnosis

Imaging with a combined positron emission tomography and computed tomography scanner shows good accuracy for diagnosing giant cell arteritis versus the gold-standard temporal artery biopsy.

25-10-2018 | Giant cell arteritis | ACR/ARHP 2018 | News

Ultrasound shows potential for early diagnosis of large vessel giant cell arteritis

Vascular ultrasound could be a contender as a first-line imaging test for diagnosing large vessel giant cell arteritis, suggests research.

22-10-2018 | Giant cell arteritis | ACR/ARHP 2018 | News

Support for PET imaging in early giant cell arteritis diagnosis

Imaging with a combined positron emission tomography and computed tomography scanner shows good accuracy for diagnosing giant cell arteritis versus the gold-standard temporal artery biopsy.

22-10-2018 | Giant cell arteritis | ACR/ARHP 2018 | Video

Axillary artery ultrasound proposed as first-line imaging test for large vessel giant cell arteritis

Berit Dalsgaard Nielsen discusses Aarhus University study findings showing the potential for ultrasound as a first-line imaging test for diagnosing large vessel inflammation in patients with suspected giant cell arteritis (4:57).

Ultrasound shows potential for early diagnosis of large vessel giant cell arteritis

Vascular ultrasound could be a contender as a first-line imaging test for diagnosing large vessel giant cell arteritis, suggests research.

27-09-2018 | Giant cell arteritis | Article

Full blood count as an ancillary test to support the diagnosis of giant cell arteritis

Oh LJ et al. Intern Med J 2018; 48: 408–413. doi: 10.1111/imj.13713

17-09-2018 | Large-vessel vasculitis | Review | Article

Diagnosis and differential diagnosis of large-vessel vasculitides

Keser G, Aksu K. Rheumatol Int 2018. doi: 10.1007/s00296-018-4157-3

29-08-2018 | Giant cell arteritis | Article

Additional costs of polymyalgia rheumatica with giant‐cell arteritis

Mounié M et al. Arthritis Care Res 2018. doi: 10.1002/acr.23736

13-07-2018 | Giant cell arteritis | News

Prolonged tocilizumab treatment needed to suppress GCA inflammation

An analysis of inflammatory markers suggests that patients with giant cell arteritis who are treated with tocilizumab still have subclinical disease activity during early remission, but not after 1 year of treatment.

28-06-2018 | Giant cell arteritis | Article

Immuno-monitoring reveals an extended subclinical disease activity in tocilizumab-treated giant cell arteritis

Gloor AD et al. Rheumatology (Oxford) 2018: key158. doi: 10.1093/rheumatology/key158

Vasculitis associated with immune checkpoint inhibitors: A systematic review

This study sought to conduct a systematic review of the literature to determine the number of clinical cases of vasculitis that have been reported so far with the use of immune checkpoint inhibitors, and explore the clinical commonalities that exist between these cases [read more].
Daxini A, Cronin K, Sreih AG. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4177-0

19-06-2018 | Vasculitis | Article

Vasculitis associated with immune checkpoint inhibitors: A systematic review

Daxini A, Cronin K, Sreih AG. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4177-0

30-04-2018 | Giant cell arteritis | News

Further investigation of ustekinumab in giant cell arteritis warranted

Preliminary study results suggest that the interleukin-12/23 inhibitor ustekinumab may be a promising treatment option for patients with giant cell arteritis.

25-04-2018 | Giant cell arteritis | Article

CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis

Ciccia F et al. Rheumatology (Oxford) 2018; Advance online publication. doi: 10.1093/rheumatology/key106

02-04-2018 | Giant cell arteritis | Review | Article

Recent advances in giant cell arteritis

Guevara M, Kollipara CS. Curr Rheumatol Rep 2018; 20: 25. doi: 10.1007/s11926-018-0737-1

21-03-2018 | Vasculitis | Review | Article

Vasculitis in Africa

Genga E, Oyoo O, Adebajo A. Curr Rheumatol Rep 2018; 20: 4. doi: 10.1007/s11926-018-0711-y

Image Credits